About

Dr. Peter Barlow BSc (Hons) PhD FHEA FRSB is an Associate Professor of Immunology and Infection, and Director of Research of the School of Applied Sciences at Edinburgh Napier University, Scotland, UK

Peter graduated with a PhD from Edinburgh Napier in 2004 with a thesis that examined the effects of nanoparticles on macrophage mediated clearance mechanisms in the lungs, under the direction of Prof. Vicki Stone

In 2005, he took up a post in the MRC / University of Edinburgh Centre for Inflammation Research to work in the laboratory of Dr. Donald Davidson as part of the Lung Inflammation Group. It was in this role that he developed an interest in the immunomodulatory activities of Cationic Host Defence Peptides (CHDP) and the ways in which they could influence cell death pathways in the context of acute infection and inflammation.

In 2009, Peter moved to the United States, where he worked within the Influenza Division of the US Centers for Disease Control & Prevention (CDC) in Atlanta, Georgia.  In CDC he developed expertise in handling highly pathogenic avian influenza viruses and took part in the global response to the 2009 novel H1N1 pandemic. He also developed his own program of research relating to the antiviral activities of CHDP on influenza viruses.

In June 2011, Peter returned to Edinburgh to take up the post of Lecturer and Principal Investigator in Immunotoxicology at Edinburgh Napier University. In October 2013, Peter was awarded a University Readership and in January 2015 was appointed Director of Research for the School of Life, Sport and Social Sciences (now called the School of Applied Sciences). Peter is also a member of Edinburgh Infectious Diseases, the hub for infectious disease research in Edinburgh, as well as Secretary of the British Society for Immunology Inflammation Affinity Group.  He is also a member of the British Society for Immunology and Fellow of the Royal Society of Biology.

Peter is passionate about public engagement with science and is a media spokesperson for the British Society for Immunology.  He has been interviewed by, or had comments published in, a number of outlets  including BBC News, Sky News, BBC Radio, ITN News, STV News, Scotland Tonight, LBC Radio, The Daily Mail, The Telegraph, The Herald, The Scotsman, The Daily Express, The Daily Record, The Edinburgh Evening News, Deadline News,  Yahoo News, ABC News (USA), NBC News (USA), CBS News (USA), Washington Post (USA), Fox News (USA), The New York Post (USA), The Associated Press, Agence France Presse, Voice of America News (USA, France) and in online platforms The Huffington Post & IFL Science.